{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:01:40Z","timestamp":1763704900634,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["631576"],"award-info":[{"award-number":["631576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bbrc.2014.01.047","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T19:17:08Z","timestamp":1390418228000},"page":"332-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy"],"prefix":"10.1016","volume":"444","author":[{"given":"Christudas","family":"Morais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Vesey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-708X","authenticated-orcid":false,"given":"Jennifer","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda C.","family":"Gobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.01.047_b0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.112.128413","article-title":"Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement","volume":"127","author":"Pagidipati","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2014.01.047_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.01.047_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physiol.00043.2010","article-title":"The athlete\u2019s heart vs. the failing heart: can signaling explain the two distinct outcomes?","volume":"26","author":"Weeks","year":"2011","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.bbrc.2014.01.047_b0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ki.1993.383","article-title":"Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin","volume":"44","author":"Fellner","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2014.01.047_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2004.08.051","article-title":"Epoetin alfa\u2019s effect on left ventricular hypertrophy and subsequent mortality","volume":"100","author":"Jones","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/med.21259","article-title":"The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use","volume":"33","author":"Sorg","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2014.01.047_b0040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/mvre.2002.2426","article-title":"Erythropoietin and VEGF exhibit equal angiogenic potential","volume":"64","author":"Jaquet","year":"2002","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbrc.2014.01.047_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1620\/tjem.227.83","article-title":"Current perspectives on protective roles of erythropoietin in cardiovascular system: erythropoietin receptor as a novel therapeutic target","volume":"227","author":"Kagaya","year":"2012","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.bbrc.2014.01.047_b0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fj.03-1289fje","article-title":"Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury","volume":"18","author":"Wright","year":"2004","journal-title":"Faseb J."},{"key":"10.1016\/j.bbrc.2014.01.047_b0055","doi-asserted-by":"crossref","first-page":"H522","DOI":"10.1152\/ajpheart.00357.2006","article-title":"Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells","volume":"292","author":"Prunier","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0060","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2011.592","article-title":"Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial","volume":"305","author":"Najjar","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2014.01.047_b0065","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1001\/jama.2011.600","article-title":"Evaluation of agents to reduce infarct size: it can be quite REVEALing","volume":"305","author":"Bhatt","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2014.01.047_b0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3858\/emm.2009.41.4.025","article-title":"Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts","volume":"41","author":"Jeong","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2014.01.047_b0075","first-page":"H452","article-title":"Sympathetic changes during development of cardiac hypertrophy in aortic-constricted rats","volume":"255","author":"Siri","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0080","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1074\/jbc.274.14.9760","article-title":"Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy","volume":"274","author":"Zou","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.01.047_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1479-5876-11-130","article-title":"A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats","volume":"11","author":"Chowdhury","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2014.01.047_b0090","first-page":"H638","article-title":"Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart","volume":"269","author":"Boluyt","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01008018","article-title":"In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats","volume":"430","author":"Nakatsuji","year":"1997","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbrc.2014.01.047_b0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCRESAHA.113.301152","article-title":"Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction","volume":"113","author":"Konstandin","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2014.01.047_b0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00395-013-0375-8","article-title":"Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth","volume":"108","author":"Konstandin","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2014.01.047_b0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0008-6363(96)00119-8","article-title":"Fibronectin and basement membrane in cardiovascular organogenesis and disease pathogenesis","volume":"32","author":"Farhadian","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2014.01.047_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.RES.75.1.23","article-title":"Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components","volume":"75","author":"Boluyt","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2014.01.047_b0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.01.047_b0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-2828(08)80003-X","article-title":"The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function","volume":"27","author":"Brand","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0135","first-page":"801","article-title":"Immunohistochemical study of fibronectin in experimental myocardial infarction","volume":"137","author":"Casscells","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0140","first-page":"H1861","article-title":"Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen","volume":"262","author":"Villarreal","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/jmcc.1999.1065","article-title":"Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice","volume":"32","author":"Brooks","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouliere","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrc.2014.01.047_b0155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/00365510902802286","article-title":"Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro","volume":"69","author":"Wen","year":"2009","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bbrc.2014.01.047_b0160","first-page":"3098","article-title":"Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta","volume":"125","author":"Park","year":"2012","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.bbrc.2014.01.047_b0165","first-page":"205","article-title":"The association between RhEPO and FN expression in glomerular mesangial cells","volume":"54","author":"Zhou","year":"2012","journal-title":"Panminerva Med."},{"key":"10.1016\/j.bbrc.2014.01.047_b0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/glia.20931","article-title":"Erythropoietin promotes Schwann cell migration and assembly of the provisional extracellular matrix by recruiting beta1 integrin to the cell surface","volume":"58","author":"Inoue","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bbrc.2014.01.047_b0175","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/labinvest.2011.125","article-title":"Erythropoietin improves skin wound healing and activates the TGF-beta signaling pathway","volume":"91","author":"Siebert","year":"2011","journal-title":"Lab. Invest."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:43:10Z","timestamp":1716471790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0006291X14000710"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.047","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}